FERROUS LACTATE

Details

Stereochemistry	RACEMIC
Molecular Formula	2C3H5O3.Fe
Molecular Weight	233.985
Optical Activity	( + / - )
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

[Fe++].CC(O)C([O-])=O.CC(O)C([O-])=O

InChI

InChIKey=DKKCQDROTDCQOR-UHFFFAOYSA-L

InChI=1S/2C3H6O3.Fe/c2*1-2(4)3(5)6;/h2*2,4H,1H3,(H,5,6);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	Fe
Molecular Weight	55.845
Charge	2
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C3H5O3
Molecular Weight	89.07
Charge	-1
Count	MOL RATIO 2 MOL RATIO (average)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description

There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.

Originator

Approval Year

Conditions

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2,591
Anemia 70	Palliative	Not Provided 511	Unknown
Unknown 2,591
Hypochromic anemia 37	Palliative	Not Provided 511	Unknown
Unknown 2,591
Unknown 2,591
Unknown 2,591
Iron deficiency 41	Primary	Approved 8,548	Ferro Sanol Duodenal
Radioactive cesium and/or radioactive or non-radioactive thallium internal contamination 37	Curative	Approved 8,548	RADIOGARDASE
Unknown 2,591

PubMed

Show entries

Title	Date	PubMed
[Ferrous lactate as an oral iron preparation for therapeutic use].	1954 Nov 27	14348915
[FERROUS ASPARTATE IN THERAPY].	1964 Jan 1	14116934
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.	2009	19421372
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.	2010 Dec	20039148
Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.	2011 Jun 10	21439359

Showing 1 to 5 of 7 entries

Previous1 2Next

Patents

Sample Use Guides

In Vivo Use Guide

Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.

Route of Administration: Oral

In Vitro Use Guide

Unknown